to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
LUMOback is the first product by LUMO, a Palo Alto-based company founded by three entrepreneurs – including one who suffered back problems for years. Charles Wang, co-founder and CMO, shared what he’s learned since the company’s launch in 2011 and the product’s release last year.
Some of my entrepreneurially-interested coworkers at the Kauffman Foundation have an interesting article on Huffington Post right now. It dissects the organic growth of 1 Million Cups (1MC) in support of a new finding: that word of mouth networking helps build early-stage startup communities better than social media.
The innovation performance in European Union countries is on the rise—cutting in half the gap between it and the United States. However, the internal gap between EU member nations is widening.
The nurturing of new and young firms has so far not been given much attention in prominent global gatherings. International government meetings have mostly concentrated on passive SME policy and others like the World Economic Forum have treated entrepreneurs as a side ring at the circus. The maturing of the Global Entrepreneurship Congress (GEC) to fill this gap is thus a welcome development.
Since its inception, Start-Up Chile has received a considerable amount of attention for its search for bootstrappers who receive equity-free seed capital of $40,000 and a 1-year work visa in the South American country. Recently it announced the opening of its seventh round of applications—looking to select, fund, and host up to 100 startups while giving them access to a global network for those determined to make their projects global.
Both houses of Congress are still in Spring recess and will return next week. While reports differ on exactly how close Republicans and Democrats are to a deal on immigration reform, you can expect to hear a lot about the subject when they return—and in the weeks ahead.
Each day, Innovation Daily checks the pulse of global innovation--courtesy of Innovation America. Here, we take a look at a handful of relevant stories it compiled last week.
Read about the six lifescience and healthcare entrepreneurs we'll be following this week on twitter.
As a life science entrepreneur, you surely have ideas on how changing legal rules and policies could promote innovation and accelerate U.S. economic growth. The Kauffman Foundation, seeking suggestions on how to jumpstart the struggling economy, convened America’s leading legal scholars and social scientists to offer their thoughts.
The vision at Bioarray Therapeutics, a biotechnology company in Boston, is to improve cancer detection and treatment. By finding genes associated with cancer, the company is developing a diagnostic for breast cancer that can help doctors and patients choose the best treatment.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
